Search research articles
Contact Us
Filters
Showing results (681-690 of 721) with videos related to
Page
of 73
Sort By:
British Journal of Cancer
|
February 10, 2024
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
Hai-Shan Ye, Dan Zhou, Hong Li, et al.
Annals of the American Thoracic Society
|
March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Roberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Lancet Regional Health. Americas
|
March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil
Marco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
Nature Communications
|
November 13, 2022
IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection
Lei Xu, Chuan Wei, Ying Chen, et al.
Journal of Advanced Research
|
November 15, 2024
Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis
Ren-Yi Su, Chen-Hao Xu, Hai-Jun Guo, et al.
Medcomm
|
August 27, 2024
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
Modan Yang, Zuyuan Lin, Li Zhuang, et al.
The Lancet Regional Health. Western Pacific
|
October 9, 2023
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial
Yong Huo, Beijian Chen, Qiufang Lian, et al.
JACC. Asia
|
August 24, 2023
Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Litong Qi, Dexue Liu, Yanling Qu, et al.
BMJ Public Health
|
July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Juliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Cell Chemical Biology
|
June 28, 2023
Chemical genomics reveals targetable programs of human cancers rooted in pluripotency
Luca Orlando, Yannick D Benoit, Jennifer C Reid, et al.
Page
of 73
Search research articles
Search
Showing results (681-690 of 721) with videos related to
Sort By:
Page
of 73
British Journal of Cancer
|
February 10, 2024
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
Hai-Shan Ye, Dan Zhou, Hong Li, et al.
Annals of the American Thoracic Society
|
March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Roberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Lancet Regional Health. Americas
|
March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil
Marco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
Nature Communications
|
November 13, 2022
IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection
Lei Xu, Chuan Wei, Ying Chen, et al.
Journal of Advanced Research
|
November 15, 2024
Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis
Ren-Yi Su, Chen-Hao Xu, Hai-Jun Guo, et al.
Medcomm
|
August 27, 2024
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
Modan Yang, Zuyuan Lin, Li Zhuang, et al.
The Lancet Regional Health. Western Pacific
|
October 9, 2023
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial
Yong Huo, Beijian Chen, Qiufang Lian, et al.
JACC. Asia
|
August 24, 2023
Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Litong Qi, Dexue Liu, Yanling Qu, et al.
BMJ Public Health
|
July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Juliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Cell Chemical Biology
|
June 28, 2023
Chemical genomics reveals targetable programs of human cancers rooted in pluripotency
Luca Orlando, Yannick D Benoit, Jennifer C Reid, et al.
Page
of 73